Galli A - Search Results

1

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.

Gammeltoft KA, Zhou Y, Duarte Hernandez CR, Galli A, Offersgaard A, Costa R, Pham LV, Fahnøe U, Feng S, Scheel TKH, Ramirez S, Bukh J, Gottwein JM. Gammeltoft KA, et al. Among authors: galli a. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0268020. doi: 10.1128/AAC.02680-20. Epub 2021 Aug 17. Antimicrob Agents Chemother. 2021. PMID: 34097489 Free PMC article.

2

Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.

Scheel TK, Galli A, Li YP, Mikkelsen LS, Gottwein JM, Bukh J. Scheel TK, et al. Among authors: galli a. PLoS Pathog. 2013 Mar;9(3):e1003228. doi: 10.1371/journal.ppat.1003228. Epub 2013 Mar 28. PLoS Pathog. 2013. PMID: 23555245 Free PMC article.

3

Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.

Galli A, Scheel TKH, Prentoe JC, Mikkelsen LS, Gottwein JM, Bukh J. Galli A, et al. J Gen Virol. 2013 Oct;94(Pt 10):2221-2235. doi: 10.1099/vir.0.053868-0. Epub 2013 Aug 1. J Gen Virol. 2013. PMID: 23907394

4

Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus.

Galli A, Bukh J. Galli A, et al. Trends Microbiol. 2014 Jun;22(6):354-64. doi: 10.1016/j.tim.2014.02.005. Epub 2014 Mar 11. Trends Microbiol. 2014. PMID: 24636243 Review.

5

Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model.

Galli A, Mens H, Gottwein JM, Gerstoft J, Bukh J. Galli A, et al. Sci Rep. 2018 Mar 15;8(1):4619. doi: 10.1038/s41598-018-22620-2. Sci Rep. 2018. PMID: 29545599 Free PMC article.

6

Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a.

Mejer N, Fahnøe U, Galli A, Ramirez S, Benfield T, Bukh J. Mejer N, et al. Among authors: galli a. J Gen Virol. 2018 Aug;99(8):1066-1077. doi: 10.1099/jgv.0.001095. Epub 2018 Jun 21. J Gen Virol. 2018. PMID: 29927371

7

Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to Resistance.

Velázquez-Moctezuma R, Galli A, Law M, Bukh J, Prentoe J. Velázquez-Moctezuma R, et al. Among authors: galli a. J Infect Dis. 2019 Jan 1;219(1):68-79. doi: 10.1093/infdis/jiy481. J Infect Dis. 2019. PMID: 30102355 Free PMC article.

8

Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.

Velázquez-Moctezuma R, Galli A, Law M, Bukh J, Prentoe J. Velázquez-Moctezuma R, et al. Among authors: galli a. J Virol. 2019 Feb 5;93(4):e01909-18. doi: 10.1128/JVI.01909-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30487284 Free PMC article.

9

Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Prentoe J, Velázquez-Moctezuma R, Augestad EH, Galli A, Wang R, Law M, Alter H, Bukh J. Prentoe J, et al. Among authors: galli a. Proc Natl Acad Sci U S A. 2019 May 14;116(20):10039-10047. doi: 10.1073/pnas.1822002116. Epub 2019 Apr 30. Proc Natl Acad Sci U S A. 2019. PMID: 31040211 Free PMC article.

10

Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.

Mejer N, Galli A, Ramirez S, Fahnøe U, Benfield T, Bukh J. Mejer N, et al. Among authors: galli a. Virology. 2020 Jan 15;540:132-140. doi: 10.1016/j.virol.2019.09.014. Epub 2019 Sep 28. Virology. 2020. PMID: 31778898 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters